vs
Side-by-side financial comparison of Evolv Technologies Holdings, Inc. (EVLV) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $38.5M, roughly 1.2× Evolv Technologies Holdings, Inc.). Evolv Technologies Holdings, Inc. runs the higher net margin — 28.3% vs -4.8%, a 33.0% gap on every dollar of revenue. On growth, Evolv Technologies Holdings, Inc. posted the faster year-over-year revenue change (32.3% vs -47.3%). Over the past eight quarters, Evolv Technologies Holdings, Inc.'s revenue compounded faster (31.8% CAGR vs -20.2%).
Sentient Technologies was an American artificial intelligence technology company based in San Francisco. Sentient was founded in 2007 and received over $143 million in funding at different points after its inception. As of 2016, Sentient was the world's most well-funded AI company. It focused on e-commerce, online content and trading.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
EVLV vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.5M | $47.7M |
| Net Profit | $10.9M | $-2.3M |
| Gross Margin | 48.4% | — |
| Operating Margin | -20.7% | 14.3% |
| Net Margin | 28.3% | -4.8% |
| Revenue YoY | 32.3% | -47.3% |
| Net Profit YoY | 169.2% | -200.9% |
| EPS (diluted) | $0.07 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.5M | $47.7M | ||
| Q3 25 | $42.9M | $122.1M | ||
| Q2 25 | $32.5M | $85.2M | ||
| Q1 25 | $32.0M | $41.1M | ||
| Q4 24 | $29.1M | $90.5M | ||
| Q3 24 | $27.4M | $91.6M | ||
| Q2 24 | $25.2M | $94.4M | ||
| Q1 24 | $22.2M | $74.9M |
| Q4 25 | $10.9M | $-2.3M | ||
| Q3 25 | $-1.8M | $40.1M | ||
| Q2 25 | $-40.5M | $23.6M | ||
| Q1 25 | $-1.7M | $-37.4M | ||
| Q4 24 | $-15.7M | $2.3M | ||
| Q3 24 | $-30.4M | $3.6M | ||
| Q2 24 | $3.4M | $-860.0K | ||
| Q1 24 | $-11.3M | $-4.2M |
| Q4 25 | 48.4% | — | ||
| Q3 25 | 49.7% | — | ||
| Q2 25 | 49.8% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | 57.5% | — | ||
| Q3 24 | 57.8% | — | ||
| Q2 24 | 58.5% | — | ||
| Q1 24 | 54.8% | — |
| Q4 25 | -20.7% | 14.3% | ||
| Q3 25 | -20.1% | 61.8% | ||
| Q2 25 | -53.8% | 53.2% | ||
| Q1 25 | -45.0% | -70.7% | ||
| Q4 24 | -64.9% | 34.8% | ||
| Q3 24 | -70.0% | 28.0% | ||
| Q2 24 | -88.7% | 26.5% | ||
| Q1 24 | -98.8% | 14.7% |
| Q4 25 | 28.3% | -4.8% | ||
| Q3 25 | -4.2% | 32.8% | ||
| Q2 25 | -124.6% | 27.7% | ||
| Q1 25 | -5.3% | -90.9% | ||
| Q4 24 | -54.0% | 2.5% | ||
| Q3 24 | -111.3% | 4.0% | ||
| Q2 24 | 13.6% | -0.9% | ||
| Q1 24 | -50.8% | -5.6% |
| Q4 25 | $0.07 | $0.01 | ||
| Q3 25 | $-0.01 | $0.23 | ||
| Q2 25 | $-0.25 | $0.14 | ||
| Q1 25 | $-0.01 | $-0.23 | ||
| Q4 24 | $-0.10 | $0.03 | ||
| Q3 24 | $-0.19 | $0.02 | ||
| Q2 24 | $0.02 | $-0.01 | ||
| Q1 24 | $-0.07 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $49.1M | $215.5M |
| Total DebtLower is stronger | $28.6M | — |
| Stockholders' EquityBook value | $119.4M | $-261.8M |
| Total Assets | $304.4M | $396.9M |
| Debt / EquityLower = less leverage | 0.24× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $49.1M | $215.5M | ||
| Q3 25 | $56.2M | $140.4M | ||
| Q2 25 | $36.9M | $92.9M | ||
| Q1 25 | $35.0M | $108.5M | ||
| Q4 24 | $51.9M | $88.6M | ||
| Q3 24 | $56.0M | $88.2M | ||
| Q2 24 | $56.5M | $105.5M | ||
| Q1 24 | $81.0M | $121.5M |
| Q4 25 | $28.6M | — | ||
| Q3 25 | $28.5M | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | $0 | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $119.4M | $-261.8M | ||
| Q3 25 | $102.2M | $-264.2M | ||
| Q2 25 | $92.7M | $-308.2M | ||
| Q1 25 | $121.1M | $-334.1M | ||
| Q4 24 | $117.7M | $-301.3M | ||
| Q3 24 | $129.0M | $-311.3M | ||
| Q2 24 | $151.2M | $-321.7M | ||
| Q1 24 | $139.8M | $-330.5M |
| Q4 25 | $304.4M | $396.9M | ||
| Q3 25 | $304.3M | $396.1M | ||
| Q2 25 | $280.4M | $342.9M | ||
| Q1 25 | $256.0M | $327.2M | ||
| Q4 24 | $268.1M | $350.9M | ||
| Q3 24 | $278.5M | $389.5M | ||
| Q2 24 | $269.1M | $395.6M | ||
| Q1 24 | $280.0M | $438.8M |
| Q4 25 | 0.24× | — | ||
| Q3 25 | 0.28× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $15.6M | $74.6M |
| Free Cash FlowOCF − Capex | — | $74.6M |
| FCF MarginFCF / Revenue | — | 156.3% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 1.43× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.6M | $74.6M | ||
| Q3 25 | $3.5M | $47.6M | ||
| Q2 25 | $2.1M | $-15.1M | ||
| Q1 25 | $-2.5M | $20.0M | ||
| Q4 24 | $3.2M | $15.2M | ||
| Q3 24 | $3.7M | $9.9M | ||
| Q2 24 | $-21.6M | $33.5M | ||
| Q1 24 | $-16.2M | $45.0M |
| Q4 25 | — | $74.6M | ||
| Q3 25 | — | $47.6M | ||
| Q2 25 | — | $-15.1M | ||
| Q1 25 | — | $19.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $9.9M | ||
| Q2 24 | — | $33.4M | ||
| Q1 24 | — | $44.9M |
| Q4 25 | — | 156.3% | ||
| Q3 25 | — | 39.0% | ||
| Q2 25 | — | -17.7% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.8% | ||
| Q2 24 | — | 35.4% | ||
| Q1 24 | — | 60.0% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | 1.43× | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | -6.31× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
